CRISPR/Cas9-mediated targeted gene correction in amyotrophic lateral sclerosis patient iPSCs-Reference-Cited by-同舟云学术

CRISPR/Cas9-mediated targeted gene correction in amyotrophic lateral sclerosis patient iPSCs

Published:2017-04-11 Issue:5 Volume:8 Page:365-378
ISSN:1674-800X
Container-title:Protein & Cell
language:en
Short-container-title:Protein Cell

Author:

Wang Lixia,Yi Fei,Fu Lina,Yang Jiping,Wang Si,Wang Zhaoxia,Suzuki Keiichiro,Sun Liang,Xu Xiuling,Yu Yang,Qiao Jie,Belmonte Juan Carlos Izpisua,Yang Ze,Yuan Yun,Qu Jing,Liu Guang-Hui^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Drug Discovery,Biochemistry,Biotechnology

Link

http://link.springer.com/article/10.1007/s13238-017-0397-3/fulltext.html

Reference74 articles.

1. Al-Chalabi A, Hardiman O (2013) The epidemiology of ALS: a conspiracy of genes, environment and time. Nat Rev Neurol 9:617–623

2. Alexianu ME, Ho BK, Mohamed AH, La Bella V, Smith RG, Appel SH (1994) The role of calcium-binding proteins in selective motoneuron vulnerability in amyotrophic lateral sclerosis. Ann Neurol 36:846–858

3. Anders S, Huber W (2010) Differential expression analysis for sequence count data. Genome Biol 11:1–12

4. Aronica E, Catania MV, Geurts J, Yankaya B, Troost D (2001) Immunohistochemical localization of group I and II metabotropic glutamate receptors in control and amyotrophic lateral sclerosis human spinal cord: upregulation in reactive astrocytes. Neuroscience 105:509–520

5. Baechtold H, Kuroda M, Sok J, Ron D, , Lopez BS, Akhmedov AT (1999) Human 75-kDa DNA-pairing protein is identical to the pro-oncoprotein TLS/FUS and is able to promote D-loop formation. J Biol Chem 274:34337–34342

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in CRISPR-Based Therapies for Genetic Modulation in Neurodegenerative Disorders;Current Gene Therapy;2025-02

2. A comprehensive review on the current status of CRISPR based clinical trials for rare diseases;International Journal of Biological Macromolecules;2024-10

3. In vivo and ex vivo gene therapy for neurodegenerative diseases: a promise for disease modification;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-05-22

4. Discovery of a novel homozygous SOD1 truncating variant bolsters infantile SOD1 deficiency syndrome;Molecular Biology Reports;2024-04-26

5. Breaking the amyotrophic lateral sclerosis early diagnostic barrier: the promise of general markers;Exploration of Neuroprotective Therapy;2023-12-27